Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-11 3:37 pm Sale | 2026-03-31 | 13G | DOLBY LABORATORIES, INC. DLB | MORGAN STANLEY MS | 5,020,777 8.200% | -1,171,464 (-18.92%) | Filing History |
| 2026-04-29 6:24 pm Purchase | 2026-03-31 | 13G | DOLBY LABORATORIES, INC. DLB | VANGUARD CAPITAL MANAGEMENT LLC | 3,193,409 5.240% | 3,193,409 (New Position) | Filing History |
| 2026-04-29 12:46 pm Purchase | 2026-03-31 | 13G | DOLBY LABORATORIES, INC. DLB | VANGUARD PORTFOLIO MANAGEMENT LLC | 5,019,900 8.240% | 5,019,900 (New Position) | Filing History |
| 2026-04-28 2:02 pm Sale | 2026-03-31 | 13G | DOLBY LABORATORIES, INC. DLB | Bank of New York Mellon Corp BK | 4,499,820 7.400% | -1,209,373 (-21.18%) | Filing History |
| 2026-03-26 6:03 pm Sale | 2026-03-13 | 13G | DOLBY LABORATORIES, INC. DLB | VANGUARD GROUP INC | 0 0.000% | -7,535,722 (Position Closed) | Filing History |
| 2026-02-13 5:33 pm Sale | 2026-02-11 | 13D | DOLBY LABORATORIES, INC. DLB | Dolby Dagmar | 34,368,358 36.000% | -933,500 (-2.64%) | Filing History |
| 2026-02-11 11:42 am Sale | 2025-12-31 | 13G | DOLBY LABORATORIES, INC. DLB | MORGAN STANLEY MS | 6,192,241 10.200% | -851,507 (-12.09%) | Filing History |
| 2025-04-30 10:55 am Purchase | 2025-03-31 | 13G | DOLBY LABORATORIES, INC. DLB | VANGUARD GROUP INC | 7,535,722 12.310% | 1,140,972 (+17.84%) | Filing History |
| 2025-04-21 1:51 pm Purchase | 2025-03-31 | 13G | DOLBY LABORATORIES, INC. DLB | Bank of New York Mellon Corp BK | 5,709,193 9.300% | 882,716 (+18.29%) | Filing History |
| 2025-02-03 4:30 pm Sale | 2025-01-30 | 13D | DOLBY LABORATORIES, INC. DLB | Dolby Dagmar | 35,301,858 36.600% | -710,875 (-1.97%) | Filing History |
| 2025-01-23 2:13 pm Purchase | 2024-12-31 | 13G | DOLBY LABORATORIES, INC. DLB | Bank of New York Mellon Corp BK | 4,826,477 8.000% | 4,826,477 (New Position) | Filing History |
| 2024-11-13 4:05 pm Sale | 2024-09-30 | 13G | DOLBY LABORATORIES, INC. DLB | Kayne Anderson Rudnick Investment Management, LLC | 208,652 0.350% | -5,211,553 (-96.15%) | Filing History |
| 2024-09-10 4:39 pm Purchase | 2024-08-30 | 13G | DOLBY LABORATORIES, INC. DLB | MORGAN STANLEY MS | 7,043,748 11.800% | 2,450,615 (+53.35%) | Filing History |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | DOLBY LABORATORIES, INC. DLB | VANGUARD GROUP INC | 6,394,750 10.800% | 382,656 (+6.36%) | Filing History |
| 2024-02-13 4:05 pm Purchase | 2023-12-31 | 13G | DOLBY LABORATORIES, INC. DLB | Kayne Anderson Rudnick Investment Management, LLC | 5,420,205 9.190% | 309,953 (+6.07%) | Filing History |
| 2024-02-08 10:43 am Purchase | 2023-12-31 | 13G | DOLBY LABORATORIES, INC. DLB | MORGAN STANLEY MS | 4,593,133 7.800% | 331,438 (+7.78%) | Filing History |
| 2024-01-24 2:27 pm Purchase | 2023-12-31 | 13G | DOLBY LABORATORIES, INC. DLB | BlackRock Inc. BLK | 5,797,685 9.800% | 2,679,900 (+85.96%) | Filing History |
| 2023-03-10 07:59 am Purchase | 2023-02-28 | 13G | DOLBY LABORATORIES, INC. DLB | VANGUARD GROUP INC | 6,012,094 10.060% | 48,422 (+0.81%) | Filing History |
| 2023-02-14 1:45 pm Purchase | 2022-12-31 | 13G | DOLBY LABORATORIES, INC. DLB | Kayne Anderson Rudnick Investment Management, LLC | 5,110,252 8.540% | 5,110,252 (New Position) | Filing History |
| 2023-02-10 1:02 pm Sale | 2022-12-31 | 13G | DOLBY LABORATORIES, INC. DLB | Clearbridge Investments LLC | 2,903,393 4.800% | -469,271 (-13.91%) | Filing History |